Summary of Significant Accounting Policies - Accounts receivable and Concentrations (Details) - item	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021	Dec. 31, 2021
Supplier risk
Concentrations
Number of suppliers			2
Total net revenue | Customer risk | Customer 1
Concentrations
Concentration risk (as a percentage)		63.00%		79.00%
Total net revenue | Customer risk | Customer 2
Concentrations
Concentration risk (as a percentage)	38.00%	17.00%	35.00%	12.00%
Total net revenue | Customer risk | Customer 3
Concentrations
Concentration risk (as a percentage)	54.00%	16.00%	53.00%
Total net revenue | Customer risk | Two major pharmaceutical distributors
Concentrations
Number of major distributors	2	2	2	2
Total net revenue | Customer risk | Minimum | Customer 1
Concentrations
Concentration risk (as a percentage)	10.00%	10.00%	10.00%	10.00%
Total accounts receivable | Credit risk | Customer 1
Concentrations
Concentration risk (as a percentage)					16.00%
Total accounts receivable | Credit risk | Customer 2
Concentrations
Concentration risk (as a percentage)			38.00%		37.00%
Total accounts receivable | Credit risk | Customer 3
Concentrations
Concentration risk (as a percentage)			55.00%		37.00%